RELENZA

Country: Israel

Bahasa: Inggeris

Sumber: Ministry of Health

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
21-03-2017

Bahan aktif:

ZANAMIVIR MICRONIZED

Boleh didapati daripada:

GLAXO SMITH KLINE (ISRAEL) LTD

Kod ATC:

J05AH01

Borang farmaseutikal:

POWDER FOR INHALATION

Komposisi:

ZANAMIVIR MICRONIZED 5 MG

Laluan pentadbiran:

INHALATION

Jenis preskripsi:

Required

Dikeluarkan oleh:

GLAXO SMITH KLINE AUSTRALIA PTY LTD

Kumpulan terapeutik:

ZANAMIVIR

Kawasan terapeutik:

ZANAMIVIR

Tanda-tanda terapeutik:

Zanamivir is indicated for the treatment of both uncomplicated acute illness due to influenza A and B virus in adults and adolescents (> or = 12 years) who have been symptomatic for no more than 48 hours and pediatric patients 7 years and older who have been symptomatic for no more than 36 hours.

Tarikh kebenaran:

2017-03-26

Cari amaran yang berkaitan dengan produk ini

Lihat sejarah dokumen